COMPANY OVERVIEW

ImmunogenX is a clinical-stage company focused on addressing the needs of individuals with suspected or diagnosed Celiac disease.

---

LOCATION

Newport Beach, CA, USA

Durham, NC, USA

---

THERAPEUTIC AREAS

Autoimmune Disease

---

WEBSITE

https://immunogenx.com/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Aug 15, 2022

ImmunogenX and Mayo Clinic Celiac Disease Study Published in Gastroenterology

Mar 18, 2021

ImmunogenX and Mayo Clinic Successfully Complete the CeliacShield Trial

Feb 13, 2020

Enrollment Begins for Latiglutenase (IMGX003) Phase 2b Trial for Treatment of Celiac Disease

Aug 8, 2019

The National Institutes of Health (NIH) Awards Another Major Grant to ImmunogenX to Conduct a Clinical Trial for Latiglutenase

Apr 9, 2019

ImmunogenX Receives Major Grant from the National Institutes of Health (NIH) to Conduct a Clinical Trial for Latiglutenase

For More Press Releases

---